194 related articles for article (PubMed ID: 3524826)
21. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
22. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
[TBL] [Abstract][Full Text] [Related]
23. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
[TBL] [Abstract][Full Text] [Related]
24. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
26. Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer.
Klein HO
Anticancer Res; 1989; 9(4):1025-6. PubMed ID: 2817784
[TBL] [Abstract][Full Text] [Related]
27. Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group.
Moertel CG; Lavin PT
Cancer Treat Rep; 1979; 63(11-12):1863-9. PubMed ID: 393381
[TBL] [Abstract][Full Text] [Related]
28. [FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
Hayakawa M; Morise K; Oka Y; Suga S; Suzuki T; Kaneshiro K; Tsunekawa H; Hayashi N; Umemura K; Yoshida H
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3073-9. PubMed ID: 2847659
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine, and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
Nakanishi F; Mogi H; Sugiishi M; Sugiura I; Ogasawara T; Kinoshita T; Hoshino A
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3413-8. PubMed ID: 3466573
[TBL] [Abstract][Full Text] [Related]
30. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC).
De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
Cancer Treat Rep; 1986 Apr; 70(4):481-5. PubMed ID: 3516397
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C
Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932
[TBL] [Abstract][Full Text] [Related]
32. [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
Fujii M; Kiura K; Okabe K; Toki H
Gan To Kagaku Ryoho; 1987 Jan; 14(1):105-8. PubMed ID: 3099647
[TBL] [Abstract][Full Text] [Related]
33. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
[TBL] [Abstract][Full Text] [Related]
34. Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1979; 63(11-12):1871-6. PubMed ID: 393382
[TBL] [Abstract][Full Text] [Related]
35. Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer.
Schnitzler G; Queisser W; Heim ME; König H; Katz R; Fritze D; Herrmann R; Arnold H; Henss H; Trux FA
Cancer Treat Rep; 1986 Apr; 70(4):477-9. PubMed ID: 3516396
[TBL] [Abstract][Full Text] [Related]
36. Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
Yeh KH; Cheng AL; Chen YC; Chen BR; Lee WJ; Lin JT; Lee PH; Chang KJ; Wang CH; Wang TH
J Formos Med Assoc; 1994 Jan; 93(1):20-4. PubMed ID: 7915575
[TBL] [Abstract][Full Text] [Related]
37. [Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer].
Louvet C; de Gramont A; Demuynck B; Varette C; Lagadec B; Cady J; Krulik M
Bull Cancer; 1991; 78(9):839-41. PubMed ID: 1751835
[TBL] [Abstract][Full Text] [Related]
38. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer.
Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD
Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983
[TBL] [Abstract][Full Text] [Related]
39. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
